DATASHEET
Host:
Rabbit
Target Protein:
N-Cadherin
Specificity:
KO-Validated
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
1000
Swiss Prot:
P19022
Source:
A synthetic peptide corresponding to a sequence within amino acids 750-850 of human N-Cadherin (NP_001783.2).
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Store at -20°C for 12 months.
Background:
This gene encodes a classical cadherin and member of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein is proteolytically processed to generate a calcium-dependent cell adhesion molecule and glycoprotein. This protein plays a role in the establishment of left-right asymmetry, development of the nervous system and the formation of cartilage and bone.
PRODUCT SPECIFIC PUBLICATIONS
- Jing Liu. et al. Exosomes Promote Atherosclerosis Progression by Regulating Circ_100696/miR-503-5p/PAPPA Axis-Mediated Vascular Smooth Muscle Cells Proliferation and Migration. INT HEART J. 2023 Sep;64(5):918-927Read more>>
VALIDATION IMAGES
Lane 1: Hela whole cell lysates; Lane 2: Hela membrane protein extract probed with N-Cadherin Polyclonal Antibody, Unconjugated (bs-55138R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Hela cell lysates; Lane 2: N-Cadherin knockout (KO) HeLa cell lysates probed with N-Cadherin Polyclonal Antibody, Unconjugated (bs-55138R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Hela cell lysates; Lane 2: A549 cell lysates; Lane 3: 293T cell lysates; Lane 4: Mouse Liver lysates; Lane 5: Mouse Brain lysates; Lane 6: Mouse Heart lysates; Lane 7: Rat Liver lysates; Lane 8: Rat Heart lysates probed with N-Cadherin Polyclonal Antibody, Unconjugated (bs-55138R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.